Borzomed 3.5mg Injection — Bortezomib 3.5mg

Description

Product Overview

Borzomed 3.5mg Injection contains Bortezomib 3.5mg, a prescription anti-cancer medicine used under medical supervision for the treatment of multiple myeloma and mantle-cell lymphoma. Bortezomib belongs to a class of medicines known as proteasome inhibitors. It works by interfering with the normal breakdown of proteins inside cells, which can lead to the death of cancer cells and help slow the progression of certain blood cancers.

This medicine must be administered only by a doctor, nurse, or qualified healthcare professional. It is not intended for self-administration. The dose, route of administration, treatment schedule, combination therapy, monitoring requirements, and treatment duration must be determined by the treating oncologist based on the patient’s diagnosis, body surface area, blood counts, liver function, kidney function, heart condition, treatment history, and overall medical condition.

Borzomed 3.5mg Injection is a prescription-only injectable anti-cancer medicine. It should not be used without professional medical supervision.

Product Details

Product Name: Borzomed 3.5mg Injection

Active Ingredient: Bortezomib

Strength: 3.5mg

Dosage Form: Injection

Pack Size: 1 Injection

Administration Route: Intravenous or subcutaneous use under medical supervision

Manufacturer / Marketer: Medicamen Biotech Ltd

Medicine Category: Anti-cancer medicine

Therapeutic Class: Anti-neoplastics

Drug Class: Proteasome inhibitor

Main Uses: Multiple myeloma and mantle-cell lymphoma

Habit Forming: No

Prescription Required: Yes

Storage: Store below 25°C

Reference Page Price: ₹5181, subject to change

Reference Page MRP: ₹5737.5, subject to change

Reference Page Expiry: Sep, 2026; actual batch expiry may vary

Return Policy: Not available / Not returnable

Order Type: Prepaid order only

Payment Method: Cryptocurrency payment only

Processing Time: 1–2 business days after payment confirmation

Bulk Orders: Not accepted

Shipping: International shipping may be available where legally permitted

Order Contact: Contact us via WhatsApp before ordering

What Borzomed 3.5mg Injection Is Used For

Borzomed 3.5mg Injection is used under medical supervision for the treatment of multiple myeloma and mantle-cell lymphoma.

Multiple myeloma is a type of blood cancer that affects plasma cells in the bone marrow. Abnormal plasma cells can build up in the bone marrow, weaken bones, reduce healthy blood-cell production, and affect immune function. Borzomed 3.5mg Injection may help control the growth of abnormal plasma cells, reduce symptoms, and improve response to treatment as part of a doctor-supervised cancer treatment plan.

Mantle-cell lymphoma is a type of non-Hodgkin lymphoma that affects certain white blood cells called B lymphocytes. Borzomed 3.5mg Injection may be used to slow disease progression, reduce tumour burden, and improve the effectiveness of combination cancer therapy.

The exact indication, dose, treatment cycle, route of administration, and combination medicines must always be confirmed by the treating oncologist.

How Borzomed 3.5mg Injection Works

Borzomed 3.5mg Injection contains Bortezomib, a proteasome inhibitor. Proteasomes are structures inside cells that help break down proteins. Cancer cells often depend on this protein-breakdown process to survive and multiply.

Bortezomib blocks or slows the breakdown of proteins inside cells. As a result, proteins build up inside cancer cells, which can interfere with their survival and lead to cancer-cell death. This action may help slow down or control the growth of cancer cells in multiple myeloma and mantle-cell lymphoma.

Because this medicine can also affect healthy cells, especially blood cells and nerve cells, patients require regular medical monitoring during treatment.

How Borzomed 3.5mg Injection Is Given

Borzomed 3.5mg Injection must be given only by a doctor, nurse, or qualified healthcare professional in a hospital, clinic, or medical treatment setting.

General administration guidance:

• This medicine is given by injection under medical supervision.
• It may be administered intravenously or subcutaneously depending on the doctor’s treatment plan.
• Do not self-administer this medicine.
• The dose and schedule must be decided by the treating doctor.
• The doctor may calculate the dose based on body surface area and treatment condition.
• Do not skip scheduled doses unless advised by your doctor.
• Complete the treatment course as recommended by your doctor.
• Blood tests may be required before and during treatment.
• Do not change the dose, route, or treatment schedule by yourself.

Taking or receiving this medicine incorrectly may cause serious side effects. Always follow your doctor’s instructions carefully.

Common Side Effects

Common side effects of Borzomed 3.5mg Injection may include:

• Fatigue
• Nausea
• Vomiting
• Loss of appetite
• Decreased white blood cell count
• Lymphopenia
• Decreased sodium level in the blood
• Decreased calcium level in the blood
• Low blood platelets
• Anemia
• Dizziness
• Tiredness
• Weakness
• Increased risk of infection
• Increased risk of bleeding
• Tingling, numbness, pain, or burning sensation in hands or feet
• Cough
• Shortness of breath
• Swelling of the feet
• Skin rash or itching
• Hair thinning or brittle hair in some patients

Some side effects may improve as the body adjusts to treatment. However, patients should contact their doctor if side effects persist, worsen, or become difficult to tolerate.

Seek urgent medical advice if symptoms include fever, chills, signs of infection, unusual bleeding, severe weakness, shortness of breath, chest tightness, severe dizziness, fainting, confusion, vision changes, seizures, swelling of the feet, changes in heartbeat, severe numbness, or severe skin reaction.

Important Safety Information

Borzomed 3.5mg Injection is a prescription injectable anti-cancer medicine and must be used only under medical supervision.

Important warnings:

• This medicine must not be self-administered.
• It should be administered only by trained healthcare professionals.
• Do not use this medicine without a valid prescription.
• Inform your doctor if you have liver disease.
• Inform your doctor if you have kidney disease.
• Inform your doctor if you have heart disease.
• Inform your doctor if you have bleeding problems.
• Inform your doctor if you have low blood counts.
• Inform your doctor if you have numbness, tingling, burning, or nerve problems in the hands or feet.
• Inform your doctor if you develop memory loss, confusion, trouble thinking, vision problems, seizures, or severe headache.
• This medicine may reduce red blood cells, white blood cells, and platelets.
• Reduced white blood cells may increase infection risk.
• Reduced platelets may increase bleeding risk.
• Regular blood tests are usually required during treatment.
• Heart, liver, kidney, and uric acid monitoring may be required.
• Effective contraception is important during treatment.
• This medicine is not recommended during pregnancy unless clearly advised by a doctor.
• This medicine is unsafe during breastfeeding.
• Do not drive or operate machinery if you feel tired, dizzy, sleepy, faint, or have blurred vision.
• Tell your doctor about all medicines, supplements, and herbal products you are taking.

Pregnancy and Breastfeeding Warning

Borzomed 3.5mg Injection is not recommended during pregnancy because it may harm the unborn baby. It may still be used only when a doctor decides that the potential benefit outweighs the potential risk.

Both male and female patients should follow effective contraception guidance during treatment and for the period recommended by their doctor after the final dose.

Borzomed 3.5mg Injection is unsafe during breastfeeding. Breastfeeding should be avoided during treatment unless the doctor confirms otherwise.

Driving, Alcohol, Kidney, and Liver Advice

Alcohol: It is not clearly known whether alcohol is safe with Borzomed 3.5mg Injection. Consult your doctor before drinking alcohol during treatment.

Driving: This medicine may cause tiredness, dizziness, fainting, sleepiness, or blurred vision. Do not drive or operate machinery if these symptoms occur.

Kidney: Use with caution in patients with kidney disease. Dose adjustment or medical monitoring may be needed.

Liver: Use with caution in patients with liver disease. Dose adjustment or medical monitoring may be needed.

Monitoring During Treatment

Patients receiving Borzomed 3.5mg Injection may require regular medical monitoring.

Doctors may monitor:

• Complete blood count
• White blood cell count
• Platelet count
• Red blood cell count
• Liver function
• Kidney function
• Heart condition
• Blood uric acid level
• Electrolyte levels
• Signs of infection
• Signs of bleeding
• Symptoms of peripheral neuropathy
• Tumour response through scans or laboratory tests

Regular monitoring helps reduce the risk of serious side effects and supports safer treatment management.

Drug Interaction Notice

Borzomed 3.5mg Injection may interact with other medicines. Some medicines may reduce the effectiveness of bortezomib or increase the risk of side effects.

Medicines that may require special attention include:

• Phenobarbitone
• Carbamazepine
• Enzalutamide
• Fosphenytoin
• Phenytoin
• Other anti-cancer medicines
• Medicines that affect the liver enzymes
• Medicines that increase bleeding risk
• Medicines that affect blood pressure or heart rhythm

Do not start, stop, or change any medicine during treatment unless your doctor approves it. Always inform your doctor about all current medicines before receiving Borzomed 3.5mg Injection.

Storage Instructions

Store Borzomed 3.5mg Injection below 25°C.

Keep the medicine in its original packaging and protect it from excessive heat, moisture, and direct sunlight. Keep it out of reach and sight of children. Do not use the medicine after the expiry date printed on the package.

Final storage instructions should always follow the actual product label, pharmacist’s guidance, and local handling requirements for injectable anti-cancer medicines.

Pack Size and Batch Information

Borzomed 3.5mg Injection is listed as Bortezomib 3.5mg injection.

Common listed pack information: 1 Injection.

Final packaging, vial presentation, batch number, expiry date, price, and product appearance may vary depending on current stock and supply batch. Please contact us via WhatsApp to confirm availability before placing an order.

Ordering Information

Please contact us via WhatsApp before placing an order.

Before processing your order, please confirm:

• Required product name and strength
• Required quantity
• Current stock availability
• Prescription or medical-document requirements
• Destination country
• Shipping eligibility
• Final payment amount
• Cryptocurrency payment details

Orders are prepaid only. We do not accept bulk orders.

Payment Policy

We currently support cryptocurrency payment only.

• Full prepayment is required before order processing.
• Orders are processed only after payment confirmation.
• Cryptocurrency transactions are generally irreversible.
• Please confirm all product, quantity, shipping, and payment details before sending payment.
• We are not responsible for losses caused by incorrect wallet address, wrong network, or payment sent without confirmation.

Processing Time

Orders are usually processed within 1–2 business days after payment confirmation.

Processing time may vary depending on:

• Product availability
• Prescription or compliance review
• Destination-country import requirements
• Shipping-route confirmation
• Local holidays or carrier limitations
• Handling requirements for injectable medicines

Once the order has been processed, it cannot be cancelled or refunded.

Shipping Policy

International shipping may be available for eligible medicines and eligible destinations, subject to applicable laws, customs rules, prescription requirements, temperature-control requirements, and shipping-route availability.

Buyers are responsible for checking and complying with the rules of their destination country, including:

• Import regulations
• Prescription requirements
• Customs clearance
• Duties and taxes
• Customs inspections
• Product detention or seizure
• Local medicine-control laws
• Injectable medicine import requirements
• Any additional documents requested by customs or local authorities

Shipping availability does not guarantee customs clearance. Delivery may be affected by local regulations, customs review, carrier limitations, product-handling requirements, or buyer-side documentation issues.

Customs Responsibility

The buyer is responsible for all customs-related matters in the destination country.

This includes customs control, duties, taxes, import restrictions, product detention, product seizure, prescription-document requirements, injectable medicine documentation requirements, and any other local regulatory issues.

Before placing an order, buyers should confirm that the product can be legally imported, received, stored, and used in their country.

Refund and Cancellation Policy

Due to the nature of pharmaceutical and injectable anti-cancer products, once an order has been processed, it cannot be cancelled or refunded.

Refunds are not available for:

• Buyer changing their mind after processing
• Incorrect shipping details provided by the buyer
• Customs delay
• Customs detention
• Import refusal
• Product seizure
• Duties, taxes, or import fees
• Failure to provide required prescription or customs documents
• Failure to meet injectable medicine import documentation requirements
• Local legal or regulatory restrictions in the buyer’s country
• Delivery delay caused by customs or carrier review

Please confirm all order details carefully before payment.